Antiphospholipid syndrome trials in United States

In United States 7 Also abroad 50

7 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Daratumumab in Primary Antiphospholipid Syndrome
Where
Ann Arbor, Baltimore, Durham, Great Neck, New York, Rochester
Age
18 years to 65 years
People
22
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05671757
Phase 1Taking people
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Where
Amarillo, Austin, Baltimore, Chapel Hill, Columbus, Houston, Lake Success, New York, Orange, Philadelphia, Portland
Age
18 years to 85 years
People
144 worldwide
Run by
Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00
No phaseTaking people
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
Where
Durham
People
2,800
Run by
Duke University
See details and how to joinNCT00482794
No phaseTaking people
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Where
Baltimore, Chicago, New York, Oklahoma City, Salt Lake City
Age
18 years to 45 years
People
700 worldwide
Run by
Hospital for Special Surgery, New York
See details and how to joinNCT00198068
Phase 2Taking people
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Where
New York, Salt Lake City
Age
18 years to 40 years
People
55 worldwide
Run by
David Ware Branch
See details and how to joinNCT03152058
No phaseTaking people
Rheumatology Patient Registry and Biorepository
Where
New Haven
Age
18 years to 99 years
People
5,000
Run by
Yale University
See details and how to joinNCT04402086
No phaseTaking people
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Where
Sacramento
Age
1 Minute to 18 years
People
50
Run by
University of California, Davis
See details and how to joinNCT00616317